Navigation Links
EPA Presents Initial Results from Caliper Life Sciences' ToxCast Screening Effort
Date:3/19/2009

w technology to bridge the gap between in vitro assays and in vivo results and then translating those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions. For more information please visit www.caliperLS.com.

The statements in this press release regarding future events, including statements regarding Caliper's expectation of receiving approximately $3 million of task orders under its ToxCast contract with the EPA during the second half of 2009, the expectation that the EPA will begin screening a broader class of compounds during Phase II of the ToxCast program after the completion of the Phase I testing of the initial set of compounds, and Caliper's belief that the assay screening panel employed by CDAS for the ToxCast initiative will be broadly applicable for product development programs within the agricultural chemical and pharmaceutical industries, are "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those contemplated by the forward-looking statements as a result of a number of factors, including the possibility that the EPA may decide to discontinue the ToxCast screening program or that funding levels for this program may be less than expected. Further information on risks faced by Caliper are detailed under the caption "Risks Related To Our Business" in Caliper's Annual Report on Form 10-K for the year ended December 31, 2008. Our filings are available on a web site maintained by the Securities and Exchange Commission at http://www.sec.gov. Caliper does not undertake any obligation to updat
'/>"/>

SOURCE Caliper Life Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Cell Therapeutics Presents Corporate Highlights at Invest Northwest Conference
2. Agendia Presents Data Supporting MammaPrints Predictive and Prognostic Power at 2009 St. Gallen Breast Cancer Conference
3. Commonwealth Biotechnologies Presents Data at Forensic Sciences Meeting Confirming Benefits of ZyGEMs DNA Extraction Technology
4. Prous Institute Presents Innovative Approach to Drug Discovery
5. PharmAthene Presents Data for SparVax(TM) and Valortim(R), a Novel Vaccine and Anti-Toxin for the Prevention and Treatment of Anthrax Infection at the 7th Annual ASM Biodefense Meeting
6. Avid Bioservices Presents Data From Manufacturing Successes Achieved With Single-Use Bioreactor Systems
7. ExL Pharma Presents The Pharmaceutical Managed Markets Insight & Marketing for the Pharmaceutical Industry Conference
8. ImQuest Presents IND-Enabling Safety Pharmacology and Pharmacokinetic Data for the Therapeutic HIV Compound IQP-0410 at Conference on Retroviruses and Opportunistic Infections
9. AngioGenex Presents Data on its Id Targeted Anti-Angiogenesis Inhibitors at Two Scientific Conferences
10. The EntreTech Forum Presents... Greening Of America - The Conversion of Bio-Agriculture, Bio-Energy, and Bio-Products to Eco-Sustainable Businesses
11. Cordex Pharma Presents New Frontiers in Cardiovascular Medicines on January 29

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...mber 6 EUCODIS Bioscience, a compa...keting enzymes for the,chemical industry announced...nt with Bio Sidus, the leading biopharmaceutical c...gives EUCODIS Bioscience exclusive access - for th...oprietary collection of,psychrophilic bacteria str...
(Date:11/6/2009)...PRNewswire/ -- Intarcia Therapeutics, Inc. deliver...#174; continuous delivery of exenatide) program fo...nual Diabetes Technology Meeting in San Francisco,...prnh/20050301/SFTU126LOGO ) ,, Continuous Sub...s Plasma Glucose, HbA1c and Reduces Weight in a 28...
(Date:11/5/2009)... The endangered black-footed ferre...This rare carnivore feeds on prairie dogs. The p...en entire population die-offs in towns occur. The...ented a ferret breeding program and has been relea...native habitat. Unfortunately, plague can sweep t...
(Date:11/5/2009)...ay, November 5, 2009 at 4:30 p.m. Eastern Time ,...irstCall/ - OncoGenex Pharmaceuticals, Inc. ("Onco...ported unaudited financial results for the third q...d reviewed the Company,s highlights for the third ...results reflect the operations of OncoGenex Techno...
Breaking Biology Technology:EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8
...nference Call To Be Held Tuesday, April 1, 2008 At...ylight Time, HOPKINTON, Mass., March 31 Alseres,...ted consolidated financial,results for the year en...ogo: http://www.newscom.com/cgi-bin/prnh/20070608...linical, regulatory, pipeline and,business accompl...
...rst Quarter 2008 Earnings Conference Call Thursday...m. U.S. EDT, FRAZER, Pa., March 31 Cephalon, In...terly earnings conference call,covering first quar...y 1,2008., May 1, 2008 S... distributed by PRNewswire 4:50 p.m. EDT To pa...
... Fiscal year Revenue Increased 51.9% to $33.2 Mill....3% to $12.8 Million, -- The Company Provides G...K and HAIKOU, Hainan, China, March 31,/Xinhua-PRNe..."China,Pharma") (OTC Bulletin Board: CPHI) which d...nded bio-pharmaceutical products in China, today,a...
Other Biology Technology:Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights 2Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights 3Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights 4Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights 5Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights 6Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights 7Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights 8Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights 9Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights 10China Pharma Holdings, Inc. Announces Record 2007 Year End Results 2China Pharma Holdings, Inc. Announces Record 2007 Year End Results 3China Pharma Holdings, Inc. Announces Record 2007 Year End Results 4China Pharma Holdings, Inc. Announces Record 2007 Year End Results 5China Pharma Holdings, Inc. Announces Record 2007 Year End Results 6China Pharma Holdings, Inc. Announces Record 2007 Year End Results 7China Pharma Holdings, Inc. Announces Record 2007 Year End Results 8China Pharma Holdings, Inc. Announces Record 2007 Year End Results 9China Pharma Holdings, Inc. Announces Record 2007 Year End Results 10China Pharma Holdings, Inc. Announces Record 2007 Year End Results 11
(Date:11/4/2009)...LLEY, Calif., Oct. 19 Spectros, de...sing and imaging devices which shed light on life-...signed exclusive distribution deals for both its T...markets covered include Australia, New Zealand, T...iname, Italy, France, Spain, Portugal, Poland, Gre...
(Date:11/4/2009)...., Oct. 21 What,s the cost of savi...idental death resulting from prescription medicati...intentions, however, may be unaware that the lock-...eens from the ticking timebomb of prescription dru...emium-quality medical supplies, has formed an excl...
(Date:11/4/2009)...HILL Scientists at the University of North Caroli...rsity of California, San Francisco have developed ...ew target diseases for existing drugs. , The res...pares how similar the structures of all known drug...-- known as ligands -- of disease targets within t...
Breaking Biology News(10 mins):Spectros Signs New International Distribution Deals 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3Study points to new uses, unexpected side effects of already existing drugs 2PediaPals to Market Pediatric Exam Tables and Medical Equipment on Target com 54167 1PediaPals to Market Pediatric Exam Tables and Medical Equipment on Target com 54167 2PediaPals to Market Pediatric Exam Tables and Medical Equipment on Target com 54167 3Video 3A People With Pain Healthcare Providers Sound Off in First Ever Online Talk Show About Pain 54162 1Video 3A People With Pain Healthcare Providers Sound Off in First Ever Online Talk Show About Pain 54162 2Video 3A People With Pain Healthcare Providers Sound Off in First Ever Online Talk Show About Pain 54162 3Video 3A People With Pain Healthcare Providers Sound Off in First Ever Online Talk Show About Pain 54162 4Video 3A People With Pain Healthcare Providers Sound Off in First Ever Online Talk Show About Pain 54162 5BrainScope 28TM 29 Receives FDA Clearance for Portable EEG Device 54157 1BrainScope 28TM 29 Receives FDA Clearance for Portable EEG Device 54157 2BrainScope 28TM 29 Receives FDA Clearance for Portable EEG Device 54157 3
...ew study by researchers from Columbia University,s...the most challenging issues in infant health and p... countries. In these settings, HIV-infected mothe...their infants, they should exclusively breast-feed...fter birth. But according to the study conducted i...
... Pennsylvania State University College of Medicine...fficacy of imiquimod, a clinically important immun...tumor activity, is dependent on the Opioid Growth ...on. This discovery, reported in the August 08 iss...s new insights into a widely used drug that may le...
...- Scientists at Harvard University and the Univers...lution is strongly shaped by genes, efforts to pre...Their study also suggests that the cost of errors ...teins themselves, rather than the loss of function...ng-lived cells, like neurons, and cause neurodegen...
Other Biology News:Early cessation of breastfeeding by HIV+ women in poor countries and child survival 2Early cessation of breastfeeding by HIV+ women in poor countries and child survival 3Imiquimod, an immune response modifier, is dependent on the OGF-OGFr signaling pathway 2Various species' genes evolve to minimize protein production errors 2Various species' genes evolve to minimize protein production errors 3
Helios Gene Gun Low-Pressure System, 100-120 V from Bio-Rad
500 Optimization Kit, PDS-1000 He and Hepta systems from Bio-Rad
... Arrays can be used to test the crossreactivity of...t are commonly used as blocking reagents or antige...ent protein preparations on a nitrocellulose membr...eactivity and species specificity, QC of purified ...
...y Life Sciences can provide custom microplate coat...plate processing equipment that dispenses and wash...date virtually any lot size of the following forma...and 12 well strips, 96 well microplate, ...
Biology Products: